Cargando…

Blood Levels of Co-inhibitory-Receptors: A Biomarker of Disease Prognosis in Multiple Sclerosis

Background: The clinical course of multiple sclerosis ranges from benign with little disease progression and minimal disability, to severe disease requiring intensive medical treatment. There are no reliable circulating biomarkers for predicting disease outcome. Co-inhibitory receptors regulate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lavon, Iris, Heli, Coral, Brill, Livnat, Charbit, Hanna, Vaknin-Dembinsky, Adi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524709/ https://www.ncbi.nlm.nih.gov/pubmed/31134049 http://dx.doi.org/10.3389/fimmu.2019.00835

Ejemplares similares

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO)
por: Vaknin-Dembinsky, Adi, et al.
Publicado: (2016)

Cerebrospinal fluid of progressive multiple sclerosis patients reduces differentiation and immune functions of oligodendrocyte progenitor cells
por: Zveik, Omri, et al.
Publicado: (2022)

Sera of Neuromyelitis Optica Patients Increase BID-Mediated Apoptosis in Astrocytes
por: Zveik, Omri, et al.
Publicado: (2022)

Effect of cladribine on COVID-19 serology responses following two doses of the BNT162b2 mRNA vaccine in patients with multiple sclerosis
por: Brill, Livnat, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab
por: Brill, Livnat, et al.
Publicado: (2022)

COVID-19 in Cladribine-treated patient with multiple sclerosis
por: Haham, Nitsan, et al.
Publicado: (2021)

Clinical outcomes of COVID-19 in patients with multiple sclerosis treated with ocrelizumab in the pre- and post-SARS-CoV-2 vaccination periods: Insights from Israel
por: Weberpals, Janick, et al.
Publicado: (2022)

Volumetric Brain Loss Correlates With a Relapsing MOGAD Disease Course
por: Rechtman, Ariel, et al.
Publicado: (2022)

Longitudinal humoral response in MS patients treated with cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine()
por: Brill, Livnat, et al.
Publicado: (2022)

NMO-IgG and AQP4 Peptide Can Induce Aggravation of EAMG and Immune-Mediated Muscle Weakness
por: Mizrachi, Tehila, et al.
Publicado: (2018)

Age-Related Clinical Presentation of MOG-IgG Seropositivity in Israel
por: Brill, Livnat, et al.
Publicado: (2021)

Neuroinflammation Modulation via α7 Nicotinic Acetylcholine Receptor and Its Chaperone, RIC-3
por: Mizrachi, Tehila, et al.
Publicado: (2021)

Detection of Glycan Shedding in the Blood: New Class of Multiple Sclerosis Biomarkers?
por: DellaValle, Brian, et al.
Publicado: (2018)

Mechanistic and Biomarker Studies to Demonstrate Immune Tolerance in Multiple Sclerosis
por: Docampo, María José, et al.
Publicado: (2022)

Using personalized prognosis in the treatment of relapsing multiple sclerosis: A practical guide
por: Van Wijmeersch, Bart, et al.
Publicado: (2022)

Kappa free light chains index in multiple sclerosis very long-term prognosis
por: Arroyo-Pereiro, Pablo, et al.
Publicado: (2023)

Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy
por: Alfarra, Helmi, et al.
Publicado: (2020)

Inhibitory Immune Checkpoint Receptors and Ligands as Prognostic Biomarkers in COVID-19 Patients
por: Al-Mterin, Mohammad A., et al.
Publicado: (2022)

Inhibition of Effector Function but Not T Cell Activation and Increase in FoxP3 Expression in T Cells Differentiated in the Presence of PP14
por: Ochanuna, Zohar, et al.
Publicado: (2010)

T Cell Vaccination Benefits Relapsing Progressive Multiple Sclerosis Patients: A Randomized, Double-Blind Clinical Trial
por: Karussis, Dimitrios, et al.
Publicado: (2012)

Suppression of neuroinflammation by an allosteric agonist and positive allosteric modulator of the α7 nicotinic acetylcholine receptor GAT107
por: Mizrachi, Tehila, et al.
Publicado: (2021)

Identification and Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Relapsing-Remitting Multiple Sclerosis
por: Li, Meng, et al.
Publicado: (2021)

The Soluble Form of Toll-Like Receptor 2 Is Elevated in Serum of Multiple Sclerosis Patients: A Novel Potential Disease Biomarker
por: Hossain, Md Jakir, et al.
Publicado: (2018)

Androgen receptor: a potential therapeutic target for glioblastoma
por: Zalcman, Nomi, et al.
Publicado: (2018)

Description of 3 patients with myasthenia gravis and COVID-19
por: Rein, Netaniel, et al.
Publicado: (2020)

Pattern Recognition Receptors in Multiple Sclerosis and Its Animal Models
por: Deerhake, M. Elizabeth, et al.
Publicado: (2019)

Specific myeloid signatures in peripheral blood differentiate active and rare clinical phenotypes of multiple sclerosis
por: Vakrakou, Aigli G., et al.
Publicado: (2023)

Discovery of Novel Biomarkers for Diagnosing and Predicting the Progression of Multiple Sclerosis Using TMT-Based Quantitative Proteomics
por: Shi, Yijun, et al.
Publicado: (2021)

Potential of PINK1 and PARKIN Proteins as Biomarkers for Active Multiple Sclerosis: A Japanese Cohort Study
por: Cossu, Davide, et al.
Publicado: (2021)

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer’s disease and multiple sclerosis: a systematic review
por: Temmerman, Joke, et al.
Publicado: (2023)

The Role of Astrocytes in Multiple Sclerosis
por: Ponath, Gerald, et al.
Publicado: (2018)

The Cerebrospinal Fluid in Multiple Sclerosis
por: Deisenhammer, Florian, et al.
Publicado: (2019)

Digital Twins for Multiple Sclerosis
por: Voigt, Isabel, et al.
Publicado: (2021)

Rehabilitation treatment of multiple sclerosis
por: Duan, Haoyang, et al.
Publicado: (2023)

Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis
por: Nytrova, Petra, et al.
Publicado: (2022)

Expression of macrophage migration inhibitory factor and its receptor CD74 in systemic sclerosis
por: Baños-Hernández, Christian Johana, et al.
Publicado: (2021)

Dual role of peripheral B cells in multiple sclerosis: emerging remote players in demyelination and novel diagnostic biomarkers
por: Torres Iglesias, Gabriel, et al.
Publicado: (2023)

Activation of Blood CD3(+)CD56(+)CD8(+) T Cells during Pregnancy and Multiple Sclerosis
por: de Andrés, Clara, et al.
Publicado: (2017)

RGMa Participates in the Blood–Brain Barrier Dysfunction Through BMP/BMPR/YAP Signaling in Multiple Sclerosis
por: Zhang, Lei, et al.
Publicado: (2022)

Characterization of antigen-specific CD8+ memory T cell subsets in peripheral blood of patients with multiple sclerosis
por: Liu, Pen-Ju, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lsp9c1jtkl9cg94s09ku8f9vc8